The Vitek 2 compact system has been launched in the Enteric and Invasive Disease Laboratory (EIDL), Royal Center for Disease Control (RCDC).

Today’s global healthcare challenges like Multi-Drug Resistant Organisms (MDRO) mean that microbiology labs need to be flexible and responsive to provide the right information at the right time. The efficiency of the VITEK^® 2 COMPACT instrument and VITEK^® 2 PC software offers the capacity to improve therapeutic success and patient outcomes through reliable microbial identification (ID) and antibiotic susceptibility testing (AST). The instrument also helps enhance laboratory efficiencies with reduced hands-on time and rapid reporting capabilities. All this, in a cost-effective, space-saving design. Rapid results allow clinicians to discontinue empiric therapy and prescribe targeted therapy, resulting in improved patient outcomes and enhanced antibiotic stewardship. The VITEK 2 system next-generation platform provides greater automation while increasing safety and eliminating repetitive manual operations. Designed to provide ID/AST results in as little as 5 to 8 hours, VITEK 2^® COMPACT works with economical, ready-to-use VITEK^® 2 ID/AST cards.